| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | NEUTRAL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 166.56▼ | 167.30▼ | 167.27▼ | 163.63▲ | 158.41▲ |
| MA10 | 167.51▼ | 167.67▼ | 166.79▼ | 158.94▲ | 152.13▲ |
| MA20 | 167.74▼ | 166.77▼ | 165.14▼ | 154.30▲ | 143.52▲ |
| MA50 | 167.85▼ | 163.43▲ | 159.66▲ | 148.83▲ | 138.54▲ |
| MA100 | 166.89▼ | 158.95▲ | 155.37▲ | 140.77▲ | 174.74▼ |
| MA200 | 165.44▼ | 154.81▲ | 151.22▲ | 136.01▲ | 213.00▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.328▼ | -0.381▼ | -0.286▼ | 1.302▲ | 3.110▲ |
| RSI | 25.278▼ | 44.318▼ | 53.802▲ | 67.711▲ | 62.509▲ |
| STOCH | 19.204▼ | 53.622 | 72.509 | 89.858▲ | 74.360 |
| WILL %R | -100.000▼ | -71.490 | -71.490 | -13.516▲ | -11.179▲ |
| CCI | -207.109▼ | -123.864▼ | -68.221 | 127.767▲ | 171.116▲ |
|
Friday, November 14, 2025 01:05 PM
CAMBRIDGE, Mass., Nov. 14, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has completed the acquisition of Alcyone Therapeutics, a clinical-stage biotechnology company known for its innovative ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 17/11/25 | 167.485 | 167.56 | 164.81 | 164.81 | 185,443 |
| 14/11/25 | 164.72 | 169.00 | 163.00 | 167.55 | 2,620,400 |
| 13/11/25 | 161.57 | 167.87 | 161.20 | 164.73 | 2,992,400 |
| 12/11/25 | 160.00 | 162.56 | 158.05 | 161.48 | 1,659,700 |
| 11/11/25 | 156.76 | 159.95 | 154.20 | 159.56 | 1,504,500 |
| 10/11/25 | 155.41 | 156.55 | 153.77 | 156.26 | 1,258,600 |
| 07/11/25 | 156.70 | 156.70 | 151.83 | 155.51 | 1,423,100 |
| 06/11/25 | 155.07 | 157.79 | 153.76 | 156.74 | 1,821,032 |
| 05/11/25 | 148.9512 | 153.66 | 148.90 | 153.43 | 1,724,192 |
| 04/11/25 | 150.89 | 152.90 | 149.05 | 149.33 | 2,028,900 |
|
|
||||
|
|
||||
|
|